Part B Competitive Acquisition: CMS Bows To Pressure On ASP Exemption
Executive Summary
Bowing to a major demand of both vendors and physicians, the Centers for Medicare & Medicaid Services will exempt Part B competitive acquisition program drug prices from average sales price calculations, at least for the first three years of the CAP